Literature DB >> 15280843

US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey.

David R Strutton1, Jonathan W Kowalski, Dee Anna Glaser, Paul E Stang.   

Abstract

BACKGROUND: The current epidemiologic data on hyperhidrosis are scarce and insufficient to provide precise prevalence or impact estimates.
OBJECTIVE: We sought to estimate the prevalence of hyperhidrosis in the US population and assess the impact of sweating on those affected by axillary hyperhidrosis.
METHODS: A nationally representative sample of 150,000 households was screened by mailed survey for hyperhidrosis and projected to the US population based on US census data. Ascertainment of hyperhidrosis was based on a question that asked whether participants experienced excessive or abnormal/unusual sweating.
RESULTS: The prevalence of hyperhidrosis in the survey sample was 2.9% (6800 individuals). The projected prevalence of hyperhidrosis in the United States is 2.8% (7.8 million individuals), and 50.8% of this population (4.0 million individuals) reported that they have axillary hyperhidrosis (1.4% of the US population). Only 38% had discussed their sweating with a health care professional. Approximately one third of individuals with axillary hyperhidrosis (0.5% of the US population or 1.3 million individuals) reported that their sweating is barely tolerable and frequently interferes, or is intolerable and always interferes, with daily activities.
CONCLUSION: Hyperhidrosis affects a much larger proportion of the US population than previously reported. More than half of these individuals have axillary hyperhidrosis, in which sweating can result in occupational, emotional, psychological, social, and physical impairment.

Entities:  

Mesh:

Year:  2004        PMID: 15280843     DOI: 10.1016/j.jaad.2003.12.040

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  112 in total

1.  [Focal hyperhidrosis.Quality of life, socioeconomic importance and use of internal medicinal therapy].

Authors:  B Rzany; C Müller; M Hund
Journal:  Hautarzt       Date:  2012-06       Impact factor: 0.751

2.  [Pathophysiology, clinical features and diagnosis of hyperhidrosis].

Authors:  E Hölzle; F G Bechara
Journal:  Hautarzt       Date:  2012-06       Impact factor: 0.751

3.  Nonintubated Transareolar Endoscopic Thoracic Sympathectomy with a Flexible Endoscope: Experience of 58 Cases.

Authors:  Jianfeng Chen; Jianbo Lin; Yuanrong Tu; Min Lin; Xu Li; Fancai Lai
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-09-29       Impact factor: 1.520

4.  Preservation of α-3 neuronal nicotinic acetylcholine receptor expression in sympathetic ganglia after brain death.

Authors:  Nabor Bezerra de Moura Júnior; João Carlos das-Neves-Pereira; José Ribas Milanez de Campos; Flávio Roberto Garbelini de Oliveira; Nelson Wolosker; Edwin Roger Parra; Vera Luiza Capelozzi; Fabio Biscegli Jatene
Journal:  Mol Neurobiol       Date:  2012-01-25       Impact factor: 5.590

5.  [Liposuction curettage versus Botox for axillary hyperhidrosis. A prospective study of the quality of life].

Authors:  C Ottomann; J Blazek; B Hartmann; T Muehlberger
Journal:  Chirurg       Date:  2007-04       Impact factor: 0.955

6.  [Treatment of palmar and axillary hyperhidrosis: thoracoscopic resection of the sympathetic chain].

Authors:  R Rieger; S Pedevilla; S Pöchlauer
Journal:  Chirurg       Date:  2008-12       Impact factor: 0.955

7.  [Hyperhidrosis-aetiopathogenesis, diagnosis, clinical symptoms and treatment].

Authors:  J Wohlrab; B Kreft
Journal:  Hautarzt       Date:  2018-10       Impact factor: 0.751

8.  Radiofrequency in the treatment of primary hyperhidrosis: systematic review and meta-analysis.

Authors:  Fabio Nishida Hasimoto; Daniele Cristina Cataneo; Erica Nishida Hasimoto; Aglaia Moreira Garcia Ximenes; Antônio José Maria Cataneo
Journal:  Clin Auton Res       Date:  2019-09-24       Impact factor: 4.435

9.  Comparison of EQ-5D-3L and metabolic components between patients with hyperhidrosis and the general population: a propensity score matching analysis.

Authors:  Yea-Chan Lee; Young Kyung You; Jun Hyuk Lee; Duk Hwan Moon; Sungsoo Lee; Soyoung Jeon; Hye Sun Lee; Ji-Won Lee
Journal:  Qual Life Res       Date:  2021-05-11       Impact factor: 4.147

10.  Botulinum toxin therapy for hyperhidrosis: reduction of injection site pain by nitrous oxide/oxygen mixtures.

Authors:  Lejla Paracka; Katja Kollewe; Reinhard Dengler; Dirk Dressler
Journal:  J Neural Transm (Vienna)       Date:  2015-02-04       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.